Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR | Market Cap | 4.69M +70.4% |
| Revenue (ttm) | 30.56M +74.3% |
| Net Income | 1.04M |
| EPS | 0.00 |
| Shares Out | 499.41M |
| PE Ratio | 3.13 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,268,296 |
| Open | 0.0094 |
| Previous Close | 0.0094 |
| Day's Range | 0.0094 - 0.0096 |
| 52-Week Range | 0.0030 - 0.3740 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 11, 2026 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. The company offers HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. It also provides software solutions include... [Read more]
Financial Performance
Financial StatementsNews
An FDA Panel Just Endorsed These Unproven Peptides
Outside experts—some with a vested interest in peptides—recommended adding a number of the amino acids to the FDA's bulk list, including the “Wolverine stack” touted by Joe Rogan and other influencers...
FDA panel recommends easing restrictions on several peptides
A Food and Drug Administration advisory committee narrowly voted in favor of loosening restrictions on peptides over strong objections from agency career scientists.
Eli Lilly Cleared Two More Trials For Its Next-Generation Obesity Drug. It Will Seek FDA Approval Next Year
After 80 weeks of treatment, obese, non-diabetic participants receiving retatrutide lost an average of 22.6% of their body weight while also showing improvements in several cardiometabolic risk factor...
FDA panel recommends controversial treatments
A controversial new FDA panel recommendation could affect the sale of peptides—popular treatments marketed for benefits ranging from muscle growth to weight loss. NBC News’ Anne Thompson explains why ...
An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition
The group met on July 24 to vote on whether compounding pharmacies could legally dispense certain peptides.
Shortage of butter hits city bakeries, may take 10 days for issue to resolve
Butter shortage in Pune hits city bakeries, forcing rationing and costlier sourcing; distributors cite seasonal milk-fat supply issues and FDA fake milk crackdown.
HIMS Shares Surge Over 10% Following FDA Panel Decision
HIMS Shares Surge Over 10% Following FDA Panel Decision
FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list
The vote is non-binding and still needs sign-off from the FDA.
Hims, The Surprise Winner Of The FDA Showdown With Peptides, Bounds Higher
Hims stock bounded higher Thursday after an FDA panel recommended compounding a popular peptide used in injury recovery.
HIMS Stock Surges Following FDA Advisory Panel Decision
HIMS Stock Surges Following FDA Advisory Panel Decision
There's A Hidden Gem In Eli Lilly's Weight-Loss News — And It Could Slam Compounders
Eli Lilly said Thursday it will delay filing for FDA approval of its next-gen weight-loss drug, retatrutide, until the first quarter.
Hims & Hers Health (HIMS) Surges 10.7% to $35.07
Hims & Hers Health surged 10.7% Thursday to close at $35.07 as telehealth companies pushed the FDA to legalize peptide treatments with regulatory safeguards.... The post Hims & Hers Health (HIMS) Surg...
Mumbai civic body shuts canteen at its headquarters after FDA suspends contractor’s food licence
BMC shut its HQ canteen after FDA suspended contractor Kamal Caterers’ food licence over hygiene lapses; inspection found 31 deficiencies after contamination reports.
MannKind (MNKD) Set for Potential Growth Ahead of FDA Decision
MannKind (MNKD) Set for Potential Growth Ahead of FDA Decision
FDA Reevaluates Regulations on Popular Peptides Amid Market Demand
FDA Reevaluates Regulations on Popular Peptides Amid Market Demand
FDA Moves To Scrap Outdated Food Dye Authorizations Amid 'Make America Healthy Again' Push
WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration has proposed revoking obsolete authorizations for petroleum-based food dyes Orange B and Citrus Red No. 2, citing abandoned use and out...
Inhibikase Therapeutics (IKT) Secures Orphan Drug Designation from FDA
Inhibikase Therapeutics (IKT) Secures Orphan Drug Designation from FDA
Fly Found In Buttermilk At Mumbai Civic Body Canteen, Shutdown Ordered
Following the inspection, the FDA issued a stop-business notice to the canteen operator over hygiene lapses and food safety rule violations.
Peptides could soon become widely available in the U.S. Here’s what happens next.
The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to broader use in Americans.
FDA recalls 1.6 million dozen eggs over Salmonella risk across five US states
US News: Eggs are a powerhouse of nutrients, containing a wide range of essential nutrients, including protein, vitamins, minerals, healthy fats, and more. And.
FDA to review 7 popular peptides touted for weight loss, healing and longevity
The FDA's Pharmacy Compounding Advisory Committee weighs peptides for obesity, insulin resistance, opioid withdrawal and insomnia this week.
Hims & Hers stands to gain if the FDA loosens restrictions on peptides
Hims & Hers Health is set to tap what analysts estimate could be a multi-billion-dollar market for peptides if U.S. regulators loosen manufacturing restrictions.
H. Lundbeck A/S: Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy
The U.S. FDA has granted Fast Track designation to Lu AH69593, an oral orexin 2 receptor agonist, for the treatment of patients with narcolepsy The orexin 2 receptor is critically located in the m...
Galderma CEO: GLP-1 boom creating new opportunities
Flemming Ørnskov, CEO of Galderma discusses the product categories driving growth, FDA regulation of the company's Relfydess drug, and the impact of weight loss drugs on the aesthetics industry.
Poultry firm recalls nearly 1.6 mln dozen eggs over potential salmonella, US FDA says
The U.S. Food and Drug Administration said on Wednesday that Midwest Poultry Services is recalling nearly 1.6 million dozen white shell eggs and brown cage-free shell eggs produced in Texas, as they h...